MCA logo



Extending Treatment Intervals in Neovascular Age-Related Macular Degeneration (nAMD)

nAMD central vision loss

The severity of COVID-19 and seemingly persistent nature, more than a year in now, has not only been endangering the lives of  those who have contracted the disease. In efforts to clamp down the rate of transmission, strict social distancing measures, and even lock-downs have been put in . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: